Insider Trading March 17, 2026

Sylvamo Executive Disposes $253,680 in Shares; Company Posts Modest Q4 Beat

SVP of Operational Excellence sells 6,000 shares as Sylvamo reports slight EPS and revenue outperformance but stock falls in pre-market trading

By Nina Shah SLVM
Sylvamo Executive Disposes $253,680 in Shares; Company Posts Modest Q4 Beat
SLVM

Patrick Wilczynski, Sylvamo Corp's SVP of Operational Excellence, sold 6,000 shares on March 17, 2026, in a transaction valued at $253,680. The sale was disclosed on a Form 4 with the SEC. Sylvamo reported fourth-quarter 2025 adjusted EPS of $1.08 on revenue of $890 million, each marginally above analysts' forecasts; the stock traded lower in pre-market activity and is down about 34% over the past year.

Key Points

  • Patrick Wilczynski sold 6,000 Sylvamo shares on March 17, 2026, at $42.28 per share, totaling $253,680.
  • Sylvamo's Q4 2025 adjusted EPS was $1.08 versus a $1.07 forecast, with revenue of $890 million compared with an expected $861.61 million.
  • The stock traded lower in pre-market trading and is approximately 34% below its level from a year earlier.

Transaction details

Sylvamo Corp (NYSE:SLVM) reported an insider sale by Senior Vice President, Operational Excellence, Patrick Wilczynski. According to a Form 4 filing with the Securities and Exchange Commission, Wilczynski sold 6,000 shares of common stock on March 17, 2026, at a price of $42.28 per share, for a total transaction value of $253,680.

Following the sale, Wilczynski retains direct ownership of 38,313.3962 shares of Sylvamo common stock. The filing also indicates indirect ownership of 608.57 shares through a spouse.

Market context

At the time of reporting, Sylvamo's shares are quoted at $41.64. The share price is down roughly 34% over the past year. The company's stock moved lower in pre-market trading after the release of its fourth-quarter 2025 results.

Quarterly financials

Sylvamo reported adjusted earnings per share of $1.08 for the fourth quarter of 2025, narrowly topping the analysts' forecast of $1.07. Revenue for the quarter was $890 million, compared with an anticipated $861.61 million. Those results represent modest outperformance relative to consensus estimates, while market reaction in early trading was negative.

Regulatory disclosure

The insider sale was formally disclosed via the required SEC Form 4 filing. The filing records both the direct post-transaction holdings and the indirect holdings noted above.

What this means for investors

The combination of an insider disposition and a company quarterly report that narrowly exceeded expectations provides data points that market participants can weigh when assessing the stock. The reported figures for adjusted EPS and revenue are key inputs for investor assessment of profitability and operational performance. The pre-market decline reflects how investors digested those results alongside insider activity.


Summary

Patrick Wilczynski sold 6,000 shares of Sylvamo on March 17, 2026, for $253,680. Sylvamo posted Q4 2025 adjusted EPS of $1.08 and revenue of $890 million, each above consensus. The stock traded down in pre-market activity and is down about 34% year-over-year. The sale was disclosed on a Form 4 and Wilczynski holds 38,313.3962 shares directly and 608.57 shares indirectly via spouse.

Risks

  • Insider sale - The disposition of shares by a senior executive may be interpreted by some investors as a negative signal, potentially affecting equity market sentiment.
  • Market reaction to earnings - Despite modest beats on EPS and revenue, the stock declined in pre-market trading, indicating sensitivity to quarterly results and investor expectations.
  • Price volatility - The stock's roughly 34% decline over the past year highlights elevated price movement that can impact investors' short-term returns.

More from Insider Trading

Smith Douglas Homes director increases stake with $249,011 purchase Mar 17, 2026 Penguin Solutions legal chief disposes of 4,000 shares amid product and leadership moves Mar 17, 2026 NJR CFO Sells 6,105 Shares; Company Posts Q1 Beat, Raymond James Lifts Target Mar 17, 2026 Omada Health CFO Executes $26,262 Stock Sale Amid Recent Profitability Signals Mar 17, 2026 Peloton Product Chief Sells $164,768 in Stock as Company Navigates Revenue Pressure Mar 17, 2026